http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0614366-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_084f36e3515c0ac02097238c863b9a9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7511bfa639ce8f826e108bf46aa70ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-664
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 1992-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1996-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acb1b9c923540f90a16c3b4e960fe7c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f00385eaf887989acee286a0b603208
publicationDate 1996-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0614366-B1
titleOfInvention Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours
abstract A method for treatment of human tumors which are sensitive to the compounds recited below, particularly those which have become resistant to chemotherapy. The method comprises administering an effective amount of creatine phosphate or phosphoenolpyruvic acid.
priorityDate 1991-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19147
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127782972
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID232426
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25804
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID615323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86994
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID221044
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID225642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID68527
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID171101
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84213
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127684899
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21591
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05700
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID586
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2922
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86348
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29094
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05205
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID779149
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID446630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84214
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40793
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID723995
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID34993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO60109
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID39824
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00634

Total number of triples: 57.